ReproCELL Incorporated (TYO:4978)

ReproCELL Statistics

Total Valuation

ReproCELL has a market cap or net worth of JPY 11.69 billion. The enterprise value is 5.18 billion.

Market Cap	11.69B
Enterprise Value	5.18B

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

ReproCELL has 95.03 million shares outstanding. The number of shares has increased by 1.99% in one year.

Current Share Class	95.03M
Shares Outstanding	95.03M
Shares Change (YoY)	+1.99%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	4.13%
Owned by Institutions (%)	-0.45%
Float	87.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.23
PB Ratio	1.32
P/TBV Ratio	1.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.77
EV / Sales	2.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.77

Financial Position

The company has a current ratio of 11.88

Current Ratio	11.88
Quick Ratio	11.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -6.63% and return on invested capital (ROIC) is -6.03%.

Return on Equity (ROE)	-6.63%
Return on Assets (ROA)	-5.56%
Return on Invested Capital (ROIC)	-6.03%
Return on Capital Employed (ROCE)	-9.52%
Weighted Average Cost of Capital (WACC)	7.43%
Revenue Per Employee	22.56M
Profits Per Employee	-5.97M
Employee Count	99
Asset Turnover	0.23
Inventory Turnover	4.46

Taxes

In the past 12 months, ReproCELL has paid 4.00 million in taxes.

Income Tax	4.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.79% in the last 52 weeks. The beta is 0.58, so ReproCELL's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-26.79%
50-Day Moving Average	166.12
200-Day Moving Average	171.83
Relative Strength Index (RSI)	21.94
Average Volume (20 Days)	612,365

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ReproCELL had revenue of JPY 2.23 billion and -591.00 million in losses. Loss per share was -6.24.

Revenue	2.23B
Gross Profit	1.02B
Operating Income	-860.00M
Pretax Income	-587.00M
Net Income	-591.00M
EBITDA	-786.00M
EBIT	-860.00M
Loss Per Share	-6.24

Balance Sheet

The company has 6.51 billion in cash and n/a in debt, with a net cash position of 6.51 billion or 68.47 per share.

Cash & Cash Equivalents	6.51B
Total Debt	n/a
Net Cash	6.51B
Net Cash Per Share	68.47
Equity (Book Value)	8.85B
Book Value Per Share	93.36
Working Capital	6.71B

Cash Flow

In the last 12 months, operating cash flow was -383.00 million and capital expenditures -98.00 million, giving a free cash flow of -481.00 million.

Operating Cash Flow	-383.00M
Capital Expenditures	-98.00M
Depreciation & Amortization	74.00M
Net Borrowing	n/a
Free Cash Flow	-481.00M
FCF Per Share	-5.06

Margins

Gross margin is 45.45%, with operating and profit margins of -38.51% and -26.47%.

Gross Margin	45.45%
Operating Margin	-38.51%
Pretax Margin	-26.29%
Profit Margin	-26.47%
EBITDA Margin	-35.20%
EBIT Margin	-38.51%
FCF Margin	n/a

Dividends & Yields

ReproCELL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.99%
Shareholder Yield	-1.99%
Earnings Yield	-5.06%
FCF Yield	-4.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.

Last Split Date	Aug 28, 2013
Split Type	Forward
Split Ratio	5

Scores

ReproCELL has an Altman Z-Score of 12.86 and a Piotroski F-Score of 2.

Altman Z-Score	12.86
Piotroski F-Score	2